Deirdre Somers - Jun 13, 2024 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jun 13, 2024
Transactions value $
-$38,884
Form type
4
Date filed
6/17/2024, 09:14 PM
Previous filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +13.5K +39.08% $0.00 47.9K Jun 13, 2024 Direct F1
transaction ENFN Class A Common Stock Sale -$38.9K -4.63K -9.66% $8.40 43.3K Jun 14, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full on the earlier of June 13, 2025, or the date of the 2025 annual meeting of stockholders of the issuer.
F2 Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.35 to $8.49. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.